B. Goyal

发表

Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV.

R. Mackman, J. Bilello, T. Cihlar, 2021, Journal of medicinal chemistry.

Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.

A. Kuglstatter, Brian R. Wong, J. D. Dal Porto, 2013, Bioorganic & medicinal chemistry letters.

Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases.

Ping Chen, Derek J. Norris, J. Tokarski, 2011, Bioorganic & medicinal chemistry letters.

New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.

Henry Wong, Punit Marathe, John S Tokarski, 2007, Bioorganic & medicinal chemistry letters.

A Facile Synthesis of Pyrazolo[3,4-b]pyridines

V. K. Ahluwalia, B. Goyal, 1996 .

One-pot Syntheses of 5-Oxo-1,4,5,6,7,8-hexahydroquinolinesand Pyrimido[4,5-b]quinolines using MicrowaveIrradiation and Ultrasound

V. K. Ahluwalia, U. Das, B. Goyal, 1997 .

One-Pot Syntheses of 5-Oxo-1,4,5,6,7,8-hexahydroquinolines and Pyrimido(4,5-b)quinolines Using Microwave Irradiation and Ultrasound.

V. K. Ahluwalia, U. Das, B. Goyal, 1997 .

One-Pot Synthesis of 4-Aryl-5-oxo-1,4,5,6,7,8-hexahydro-2,7,7- trimethylquinoline-3-carboxylates.

V. K. Ahluwalia, B. Goyal, 1996 .

Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases.

J. Fargnoli, Derek J. Norris, J. Tokarski, 2009, Journal of medicinal chemistry.

Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.

J. Fargnoli, J. Tokarski, J. Hunt, 2005, Bioorganic & medicinal chemistry letters.

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Jennifer B Dennison, S. Demo, M. Bennett, 2014, Molecular Cancer Therapeutics.

Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition.

P. Savy, Steve Price, A. Nadin, 2012, Journal of medicinal chemistry.

Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.

Derek J. Norris, J. Tokarski, S. D. Kimball, 2006, Bioorganic & medicinal chemistry letters.

Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.

Johannes C. Hermann, C. Lukacs, A. Kuglstatter, 2013, Bioorganic & medicinal chemistry letters.

Small Molecule Therapeutics Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

S. Demo, M. Bennett, F. Parlati, 2014 .

Pyrimidine-based inhibitors of CaMKIIdelta.

S. Sideris, Linda S Higgins, J. Higaki, 2008, Bioorganic & medicinal chemistry letters.

Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.

A. Kuglstatter, Brian R. Wong, J. D. Dal Porto, 2013, Bioorganic & medicinal chemistry letters.